N. Tkachenko

Clinical Guidelines for Providing Pharmaceutical Care to Patients with Chronic Coronary Syndrome (Method Recommendation)

Maryna Dolzhenko, Yu.M. Sіrenko, Н. А. Білоусова, N. Tkachenko et autres

RETROSPECTIVE ANALYSIS OF CLINICAL, EPIDEMIOLOGY AND PATHOMORPHOLOGICAL FEATURES OF MYOCARDIAL INFARCTION

N. Tkachenko, Олена Проценко, N. A. Remnyova, Любов Ігорівна Чумак et autres

The aim of this study is to conduct a retrospective analysis of the clinical, epidemiological, and pathomorphological features of myocardial infarction. Materials and methods: A retrospective analysis was conducted using data from medical records and autopsy results from the pathology department for …

ua (code pays fourni par la source)

Assessment of 25(OH)D status in patients with genital endometriosis and clinical efficacy of cholecalciferol in the treatment of the disease

Alexandra S. Denisova, Maria I. Yarmolinskaya, N. Tkachenko

AIM: The aim of this study was to determine the 25(OH)D status in patients with genital endometriosis compared to the control group and to analyze the clinical efficacy of cholecalciferol implication as a combined targeted therapy of the disease. MATERIALS AND METHODS: …

ru (code pays fourni par la source)

PS1106 A RETROSPECTIVE ANALYSIS OF IMMUNE THROMBOCYTOPENIA PATIENTS TREATMENT RESULTS AFTER SEQUENTIAL SWITCHING OF THROMBOPOIETIC RECEPTOR‐AGONISTS

В. В. Птушкин, О. В. Виноградова, N. Tkachenko, M. Pankrashkina et autres

Background: Immune thrombocytopenia (ITP) is an immune‐mediated disease characterized by increased platelet destruction and impaired platelet production with transient or persistent decrease in the platelet count and increased risk of bleeding. Romiplostim (R) and Eltrombopag (E) are the first thrombopoietic receptor‐agonists (TPO‐ra) …

ru, Tunisie (code pays fourni par la source)

PF336 EVALUATION OF THROMBOPOIETIN‐RECEPTOR AGONISTS (TPO‐RAS) «STOP‐THERAPY» IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Olga Vinogradova, M. Pankrashkina, N. Tkachenko, M. V. Chernikov et autres

Background: For a number of years, it has been shown that TPO‐RAs are a highly effective therapy of ITP. Still, there are few published guidelines/recommendations addressing the management of ITP patients (pts) on TPO‐RAs after they achieve continuous remission. Aims: To evaluate …

ru (code pays fourni par la source)

Podium Session 1: Prostate Cancer June 26, 2016 1050–1150

D. Robert Siemens, Henry Klotz, Axel Heidenreich, Susmita Chowdhury et autres